[Autoimmune polyendocrinopathy and chronic mucocutaneous candidiasis]

Area of Science:

• Endocrinology
• Immunology
• Infectious Diseases

Background:

• Autoimmune Polyglandular Syndrome Type 1 (APS1), also known as Whitaker syndrome, is a rare autoimmune disorder.
• It is characterized by a combination of endocrine and non-endocrine autoimmune diseases.
• Chronic mucocutaneous candidiasis is a hallmark of APS1, often presenting in early childhood.

Observation:

• This case report details a young patient diagnosed with chronic mucocutaneous candidiasis in early childhood.
• The patient subsequently developed hypoparathyroidism at age 4 and adrenal insufficiency at age 5.
• The underlying cause for susceptibility to mucocutaneous candidiasis in APS1 remains unclear.

Findings:

• The patient presented with a triad of chronic mucocutaneous candidiasis, hypoparathyroidism, and adrenal insufficiency, consistent with APS1.
• The progression of autoimmune manifestations highlights the multisystemic nature of the syndrome.
• Oral antifungal agents have significantly improved the management of mucocutaneous candidiasis in APS1.

Implications:

• Early recognition of chronic mucocutaneous candidiasis is crucial for timely diagnosis of APS1.
• Understanding the pathogenesis of APS1 can lead to novel therapeutic strategies.
• Advances in antifungal therapy offer better control of opportunistic infections in APS1 patients.